UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
KUMC mulls bio-health investment
by Nam Doo-hyun
2018-02-22 11:36
‘Gilead Sciences Korea won’t mind sales setback’
by Nam Doo-hyun
2018-02-21 15:42
‘Psoriasis treatment Taltz outperforms rivals’
by Nam Doo-hyun
2018-02-21 11:37
Cell therapy Rosmir to target anti-wrinkle market
by Nam Doo-hyun
2018-02-20 15:19
‘Novo Nordisk Korea has no plan to downsize’
by Nam Doo-hyun
2018-02-13 15:46
라인
Safer, more potent new drugs coming up this year
by Nam Doo-hyun
2018-02-12 15:54
‘New combo may become standard soft tissue sarcoma treatment’
by Nam Doo-hyun
2018-02-09 15:50
Immunotherapies claims rose on insurance coverage in 2017
by Nam Doo-hyun
2018-02-07 11:07
Korea’s drug exports increased fastest to China in 2017
by Nam Doo-hyun
2018-02-05 14:36
Will new KRPIA head back US pharma in FTA revision?
by Nam Doo-hyun
2018-02-02 14:53
라인
Overheated DHP Korea stocks face short-term trade limit
by Nam Doo-hyun
2018-01-31 15:34
Contrast medium market shrank last year
by Nam Doo-hyun
2018-01-24 15:14
Antihypertensive, antiarteriosclerotic drugs surged last year
by Nam Doo-hyun
2018-01-22 11:35
Which certificates do you need for 4th industrial revolution?
by Nam Doo-hyun
2018-01-18 12:18
Shares of ‘Celltrion trio’ plummet on profit-taking
by Nam Doo-hyun
2018-01-18 11:10
라인
‘Risk-sharing agreements improved access to expensive drugs’
by Nam Doo-hyun
2018-01-17 16:15
Korea’s pharmaceutical exports up 20% in 2017
by Nam Doo-hyun
2018-01-16 11:21
Shares of eye drops/masks makers rise on fine dust measure
by Nam Doo-hyun
2018-01-15 15:48
'Postmenopausal use of aromatase inhibitor ups fracture risk’
by Nam Doo-hyun
2018-01-15 14:42
Gaucher disease drug effective for retention, early treatment, Sanofi says
by Nam Doo-hyun
2018-01-15 10:27
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top